We recently published the annual update of our Nephron Specialty Market Model, a forecast of the specialty pharmaceutical market 2019-2023 and review of historic specialty trends 2013-2018. The market model provides an in-depth analysis of growth projections across 18 therapeutic categories with an eye toward the implications for the Specialty Distribution (SD) and Specialty Pharmacy (SP) channels – a key differentiator form other analyses of specialty market growth that makes this a popular report with both investors and industry participants.
In this installment we see that after a period of elevated mid-teens growth 2013-18, the specialty market is projected to
grow at a 7% CAGR 2018-2023E. Importantly, the rate of growth is slowing on an expanded base, but varied greatly across the therapeutic categories and channels. For more information on the Specialty market Model and Nephron Research, please email firstname.lastname@example.org